Tubio, Almera .
HRN: 20-67-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
CEFUROXIME 1.5GM (VIAL)
08/10/2023
08/16/2023
IVT
1.5g
Q8hrs
Choledocholithiasis
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes